Sahpra warns against counterfeit GLP-1 products like Ozempic, citing health risks. Only registered products should be used; ...
The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...
SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...
GLP-1 drugs could treat issues such as dementia, addictions and mental conditions. Read more at straitstimes.com.
which is one of the registered products containing GLP-1 agonists from Novo Nordisk. According to the watchdog, Ozempic in ...
‘Novo Nordisk confirmed to the HPRA that there are shortages of Ozempic 0.25mg and 0.5mg, with resupply expected in December ...
For instance, the phase III FLOW trial, which enrolled patients with type 2 diabetes and CKD, reported a 24% risk reduction in a composite kidney outcome with 1-mg ... from Novo Nordisk to ...
Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk ... or 15 mg, or Ozempic at a dose of 1 mg.
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...